ResMed Revenue 2010-2025 | RMD
ResMed annual/quarterly revenue history and growth rate from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- ResMed revenue for the quarter ending March 31, 2025 was $1.292B, a 7.92% increase year-over-year.
- ResMed revenue for the twelve months ending March 31, 2025 was $5.022B, a 9.54% increase year-over-year.
- ResMed annual revenue for 2024 was $4.685B, a 10.95% increase from 2023.
- ResMed annual revenue for 2023 was $4.223B, a 18.02% increase from 2022.
- ResMed annual revenue for 2022 was $3.578B, a 11.93% increase from 2021.
| ResMed Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $4,685 |
| 2023 | $4,223 |
| 2022 | $3,578 |
| 2021 | $3,197 |
| 2020 | $2,957 |
| 2019 | $2,607 |
| 2018 | $2,340 |
| 2017 | $2,067 |
| 2016 | $1,839 |
| 2015 | $1,679 |
| 2014 | $1,555 |
| 2013 | $1,514 |
| 2012 | $1,369 |
| 2011 | $1,243 |
| 2010 | $1,092 |
| 2009 | $921 |
| ResMed Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-03-31 | $1,292 |
| 2024-12-31 | $1,282 |
| 2024-09-30 | $1,225 |
| 2024-06-30 | $1,223 |
| 2024-03-31 | $1,197 |
| 2023-12-31 | $1,163 |
| 2023-09-30 | $1,102 |
| 2023-06-30 | $1,122 |
| 2023-03-31 | $1,117 |
| 2022-12-31 | $1,034 |
| 2022-09-30 | $950 |
| 2022-06-30 | $915 |
| 2022-03-31 | $865 |
| 2021-12-31 | $895 |
| 2021-09-30 | $904 |
| 2021-06-30 | $876 |
| 2021-03-31 | $769 |
| 2020-12-31 | $800 |
| 2020-09-30 | $752 |
| 2020-06-30 | $770 |
| 2020-03-31 | $769 |
| 2019-12-31 | $736 |
| 2019-09-30 | $681 |
| 2019-06-30 | $705 |
| 2019-03-31 | $662 |
| 2018-12-31 | $651 |
| 2018-09-30 | $588 |
| 2018-06-30 | $624 |
| 2018-03-31 | $592 |
| 2017-12-31 | $601 |
| 2017-09-30 | $524 |
| 2017-06-30 | $557 |
| 2017-03-31 | $514 |
| 2016-12-31 | $530 |
| 2016-09-30 | $465 |
| 2016-06-30 | $519 |
| 2016-03-31 | $454 |
| 2015-12-31 | $455 |
| 2015-09-30 | $412 |
| 2015-06-30 | $453 |
| 2015-03-31 | $422 |
| 2014-12-31 | $423 |
| 2014-09-30 | $380 |
| 2014-06-30 | $415 |
| 2014-03-31 | $398 |
| 2013-12-31 | $384 |
| 2013-09-30 | $358 |
| 2013-06-30 | $415 |
| 2013-03-31 | $384 |
| 2012-12-31 | $377 |
| 2012-09-30 | $340 |
| 2012-06-30 | $372 |
| 2012-03-31 | $349 |
| 2011-12-31 | $333 |
| 2011-09-30 | $315 |
| 2011-06-30 | $342 |
| 2011-03-31 | $313 |
| 2010-12-31 | $306 |
| 2010-09-30 | $282 |
| 2010-06-30 | $292 |
| 2010-03-31 | $279 |
| 2009-12-31 | $275 |
| 2009-09-30 | $247 |
| 2009-06-30 | $252 |
| 2009-03-31 | $228 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $37.575B | $4.685B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $237.070B | 28.51 |
| Boston Scientific (BSX) | United States | $155.016B | 38.81 |
| Stryker (SYK) | United States | $151.431B | 31.66 |
| EssilorLuxottica (ESLOY) | France | $128.578B | 0.00 |
| Medtronic (MDT) | Ireland | $113.826B | 16.14 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.396B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.515B | 26.54 |
| GE HealthCare Technologies (GEHC) | United States | $34.776B | 16.51 |
| Agilent Technologies (A) | United States | $34.216B | 22.31 |
| Terumo (TRUMY) | Japan | $26.620B | 34.58 |
| Koninklijke Philips (PHG) | Netherlands | $23.303B | 16.35 |
| Insulet (PODD) | United States | $21.112B | 82.87 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.610B | 11.95 |
| Baxter (BAX) | United States | $16.026B | 11.97 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.402B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.748B | 23.48 |
| Lantheus Holdings (LNTH) | United States | $5.495B | 13.86 |
| Prestige Consumer Healthcare (PBH) | United States | $3.969B | 17.73 |
| Perrigo (PRGO) | Ireland | $3.771B | 9.56 |
| Haemonetics (HAE) | United States | $3.667B | 16.70 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.393B | 28.20 |
| ICU Medical (ICUI) | United States | $3.321B | 24.49 |
| QuidelOrtho (QDEL) | United States | $2.015B | 13.86 |
| LeMaitre Vascular (LMAT) | United States | $1.891B | 42.27 |
| AtriCure (ATRC) | United States | $1.594B | 0.00 |
| Acuren (TIC) | United States | $1.327B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.269B | 12.88 |
| Green Thumb Industries (GTBIF) | United States | $1.158B | 26.05 |
| Neogen (NEOG) | United States | $1.103B | 14.11 |
| Phibro Animal Health (PAHC) | United States | $1.079B | 13.79 |
| BioLife Solutions (BLFS) | United States | $1.029B | 0.00 |
| InMode (INMD) | Israel | $0.937B | 9.45 |
| Kestra Medical Technologies (KMTS) | United States | $0.813B | 0.00 |
| Owens & Minor (OMI) | United States | $0.728B | 6.04 |
| CeriBell (CBLL) | United States | $0.671B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.639B | 0.00 |
| Evolus (EOLS) | United States | $0.593B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.544B | 0.00 |
| Valneva SE (VALN) | France | $0.487B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.443B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.424B | 0.00 |
| Surmodics (SRDX) | United States | $0.419B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.353B | 12.98 |
| Quanterix (QTRX) | United States | $0.334B | 0.00 |
| SNDL (SNDL) | Canada | $0.321B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Cerus (CERS) | United States | $0.283B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.277B | 23.33 |
| Sanuwave Health (SNWV) | United States | $0.276B | 0.00 |
| ZimVie (ZIMV) | United States | $0.274B | 12.46 |
| Cresco Labs (CRLBF) | United States | $0.258B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.256B | 0.00 |
| Brainsway (BWAY) | Israel | $0.245B | 64.88 |
| Aurora Cannabis (ACB) | Canada | $0.242B | 71.67 |
| Biote (BTMD) | United States | $0.225B | 6.34 |
| OraSure Technologies (OSUR) | United States | $0.225B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.208B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.195B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.190B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.18 |
| Organigram Global (OGI) | Canada | $0.177B | 0.00 |
| Omeros (OMER) | United States | $0.174B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.141B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 16.35 |
| Jin Medical (ZJYL) | China | $0.099B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.50 |
| TerrAscend (TSNDF) | Canada | $0.091B | 0.00 |
| Veru (VERU) | United States | $0.086B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.081B | 0.00 |
| Zynex (ZYXI) | United States | $0.080B | 0.00 |
| MacroGenics (MGNX) | United States | $0.079B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.076B | 0.00 |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Agape ATP (ATPC) | $0.067B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 57.57 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.75 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |